InChI
1S/ClHO4/c2-1(3,4)5/h(H,2,3,4,5)
SMILES string
OCl(=O)(=O)=O
InChI key
VLTRZXGMWDSKGL-UHFFFAOYSA-N
grade
ACS reagent
vapor pressure
6.8 mmHg ( 25 °C)
assay
69.0-72.0%, 70%
impurities
≤0.001% N compounds
ign. residue
≤0.003%
color
APHA: ≤10
density
1.664 g/mL at 25 °C
anion traces
SiO32- and PO43-: ≤5 ppm, chloride (Cl-): ≤0.001%, sulfate (SO42-): ≤0.001%
cation traces
Fe: ≤1 ppm
正在寻找类似产品? 访问 产品对比指南
signalword
Danger
Hazard Classifications
Acute Tox. 4 Oral - Eye Dam. 1 - Met. Corr. 1 - Ox. Liq. 1 - Skin Corr. 1A - STOT RE 2
target_organs
Thyroid
存储类别
5.1A - Strongly oxidizing hazardous materials
wgk
WGK 1
flash_point_f
235.4 °F - closed cup
flash_point_c
113 °C - closed cup
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
法规信息
新产品
此项目有
John Greenwood et al.
ACS nano, 9(5), 5520-5535 (2015-04-22)
We shine light on the covalent modification of graphite and graphene substrates using diazonium chemistry under ambient conditions. We report on the nature of the chemical modification of these graphitic substrates, the relation between molecular structure and film morphology, and
Dipanwita Das et al.
Journal of the American Chemical Society, 135(10), 4018-4026 (2013-02-28)
Catalytic four-electron reduction of O2 by ferrocene (Fc) and 1,1'-dimethylferrocene (Me2Fc) occurs efficiently with a dinuclear copper(II) complex [Cu(II)2(XYLO)(OH)](2+) (1), where XYLO is a m-xylene-linked bis[(2-(2-pyridyl)ethyl)amine] dinucleating ligand with copper-bridging phenolate moiety], in the presence of perchloric acid (HClO4) in
Dipanwita Das et al.
Journal of the American Chemical Society, 135(7), 2825-2834 (2013-02-12)
Selective two-electron plus two-proton (2e(-)/2H(+)) reduction of O(2) to hydrogen peroxide by ferrocene (Fc) or 1,1'-dimethylferrocene (Me(2)Fc) in the presence of perchloric acid is catalyzed efficiently by a mononuclear copper(II) complex, [Cu(II)(tepa)](2+) (1; tepa = tris[2-(2-pyridyl)ethyl]amine) in acetone. The E(1/2)
Kristiina Cajanus et al.
The journal of pain : official journal of the American Pain Society, 15(12), 1248-1256 (2014-09-23)
Most clinically used opioids are mu-opioid receptor agonists. Therefore, genetic variation of the OPRM1 gene that encodes the mu-opioid receptor is of great interest for understanding pain management. A polymorphism 118A>G (rs1799971) within the OPRM1 gene results in a missense
N Gyémánt et al.
British journal of cancer, 103(2), 178-185 (2010-06-17)
The multidrug resistance (MDR) proteins are present in a majority of human tumours. Their activity is important to understand the chemotherapeutic failure. A search for MDR-reversing compounds was conducted among various Betti-base derivatives of tylosin. Here, we evaluate the in
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持